Enhanced Branched Amino Acid Surfactants for Healthcare Products
Legal Citation
Summary of the Inventive Concept
This inventive concept introduces novel improvements to branched amino acid surfactants for healthcare products, enhancing their stability, bioavailability, and delivery efficiency.
Background and Problem Solved
The original patent for branched amino acid surfactants has limitations in terms of stability, delivery, and bioavailability. This new inventive concept addresses these limitations by introducing methods for preparing and stabilizing the surfactants, as well as enhancing their bioavailability and delivery efficiency.
Detailed Description of the Inventive Concept
The new claims include methods for preparing branched amino acid surfactants by mixing siloxane derivatives of amino acids with solvents and concentrating the solutions. Additionally, the inventive concept includes systems for delivering the surfactants to target sites in healthcare products, as well as compositions that enhance the bioavailability of bioactive agents. Furthermore, the inventive concept provides methods for enhancing the stability of the surfactants by adding stabilizing agents and storing the compositions at controlled temperatures. The inventive concept also includes branched amino acid surfactant compositions with pH-adjusting agents to maintain optimal pH levels.
Novelty and Inventive Step
The new claims provide a novel approach to preparing, stabilizing, and delivering branched amino acid surfactants, which is non-obvious compared to the original patent. The inventive concept's focus on enhancing bioavailability, stability, and delivery efficiency sets it apart from the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include different solvents, stabilizing agents, and pH-adjusting agents. Additionally, the inventive concept could be applied to various healthcare products, such as cosmetics, pharmaceuticals, and medical devices.
Potential Commercial Applications and Market
The enhanced branched amino acid surfactants have significant commercial potential in the healthcare industry, particularly in the development of more efficient and effective healthcare products. The target market includes pharmaceutical, cosmetic, and medical device companies seeking to improve the performance of their products.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K47/183 |
| A | A61 | A61K9/0019 |
| A | A61 | A61K9/08 |
| A | A61 | A61K9/107 |
| A | A61 | A61K31/5377 |
| A | A61 | A61K31/55 |
| A | A61 | A61K47/186 |
| A | A61 | A61K47/20 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical and healthcare product formulation, specifically surfactant chemistry with a focus on amino acid-based surface-active compounds for drug delivery and healthcare applications
Person of Ordinary Skill (PHOSITA) Profile
A skilled practitioner with expertise in organic chemistry, pharmaceutical formulation, and surfactant design, holding at least a Master's degree or equivalent professional experience in chemical engineering or pharmaceutical sciences
Obviousness Rationale
The Published Technical Disclosure presents incremental modifications to the source patent's branched amino acid surfactants that would be readily apparent to a person skilled in the art. The PTD's variations represent predictable extensions of known surfactant design principles, utilizing standard pharmaceutical formulation techniques to enhance delivery, stability, and bioavailability of existing surfactant technologies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,515 |
|---|---|
| Title | Branched amino acid surfactants for use in healthcare products |
| Assignee(s) | AdvanSix Resins & Chemicals LLC |